Facility Site Selection Requires Special Expertise
Getting a drug approved involves the effective coordination and management of scientific, clinical, regulatory and financial activities within a development program. The establishment of manufacturing capability is an integral element to successfully achieving drug approval and licensure of a manufacturing facility.

Because Biotech Facilities, and in particular Biotech Manufacturing Facilities, are extremely costly, their implementation is not a casual decision by a corporation. For biopharmaceutical companies, determining where to locate their development and manufacturing capabilities is a complex and difficult undertaking. Pharmatech has developed a methodology that incorporates the risk, costs and business factors which impact the decision to build a facility. We work with real estate developers and drug manufacturers to screen, assess and finalize facility implementation.

Pharmatech's Methodology
Pharmatech's methodology is a stepwise process designed to identify, characterize and eliminate unsuitable site solutions based upon strategic business imperatives. Throughout this process Pharmatech creates a quantifiable criteria matrix that can be used to evaluate alternatives.



Site Representation Services
Pharmatech has an extensive network of clients ranging from small development organizations to Fortune 100 companies. Pharmatech can assist developers with properties that meet the needs of the biopharmaceutical and pharmaceutical industry and identify companies that are seeking new locations for their operations.